|Bid||16.16 x 100|
|Ask||19.50 x 200|
|Day's Range||16.59 - 17.47|
|52 Week Range||2.73 - 23.40|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
On a per-share basis, the Memphis, Tennessee-based company said it had a loss of 43 cents. For the year, the company reported that its loss widened to $30.4 million, or $1.75 per share. GTx shares have ...
GTx Inc. shares surged nearly 30% in Monday trade after the company reported additional results from a phase 2 trial of its drug for postmenopausal women with stress urinary incontinence. The latest data ...
It’s a big day for GTx, Inc. (NASDAQ:GTXI). The biopharmaceutical company released positive clinical data that had many, even some of the biggest bears on the stock, commending the headway GTx has made.
Sixteen-and-a-half percent: the amount of board seats held by women at Memphis-based public companies in 2017. The latest cover story from Memphis Business Journal, “ Glass door blocks boardroom, ” looks at the gender gap that dominates corporate America’s board rooms both on a national and local level. As part of that package, MBJ reached out to all the locally based public companies and asked them to address whether the male/female ratio on its board of directors was something the company considered.
On a per-share basis, the Memphis, Tennessee-based company said it had a loss of 53 cents. GTx shares have more than doubled since the beginning of the year. The stock has climbed 42 percent in the last ...
GTx (GTXI) posts positive data from a phase II study of enobosarm for treating women with stress urinary incontinence. However, shares dip possibly with the release falling below market estimates.
On a per-share basis, the Memphis, Tennessee-based company said it had a loss of 40 cents. GTx shares have climbed 8 percent since the beginning of the year. The stock has increased almost 6 percent in ...
GTx, Inc.'s (GTXI) shares have climbed almost 99% after the company announced positive data from a phase II study, evaluating enobosarm for treating postmenopausal women with stress urinary incontinence.
The Memphis, Tennessee-based company said it had a loss of 39 cents per share. The company's shares closed at $4.29. A year ago, they were trading at $7.28. _____ This story was generated by Automated ...